January 10, 2017 / 1:05 AM / 6 months ago

BRIEF-Amgen comments on Delaware court's ruling on PCSK9 patent litigation

1 Min Read

Jan 10 (Reuters) - Amgen Inc

* Amgen statement on January 9, 2017, U.S. District court decision

* Amgen Inc - U.S. District court of Delaware denied Sanofi and Regeneron's motion to stay injunction pending appeal in ongoing PCSK9 patent litigation

* Amgen Inc says by ruling, court has extended time before injunction will be imposed by 15 days (from 30 days to 45 days) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below